All these data suggested that GZFL was able to ameliorate liver fibrosis in vitro and in vivo by modulating the crosstalk between TGF-β1/Smad2/3 and IFN-γ/STAT1/Smad7 signaling pathway via CUGBP1. Here, SMAD7 is linked to Hepatic fibrosis.